| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.37 | 0.05 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |